Numerous substrates are tyrosine phosphorylated upon CD2 stimulation of human Jurkat T cells using a mitogenic pair of CD2 monoclonal antibodies, including the phospholipase C (PLC)3'-1-p35/36 complex. Most of these substrates are identically tyrosine phosphorylated after CD3 ligation, suggesting that both stimuli share the same biochemical pathway. We show, however, in this report that a 63-kD protein is specifically phosphorylated on tyrosine residues after ligation of the CD2 molecule. The tyrosine phosphorylation of p63 can be induced independently of other substrates when using a single CD2 mAb recognizing the D66 epitope of the molecule. Importantly, this CD2-induced tyrosine phosphorylation of p63 can also occur in the absence of the CD3~" chain membrane expression, and is also distinct from the protein tyrosine kinases p56 ~ and p59f~. We demonstrate, moreover, that p63 is physically linked with PLC3r-1 and p35/36 upon CD2 stimulation. Finally, we also show that a 62-kD protein coimmunoprecipitating with the p21ras GTPase activating protein (GAP) is heavily tyrosine phosphorylated only after CD2 stimulation. This ultimately suggests that p63 may represent in fact the 62-kD protein that associates with GAP after tyrosine phosphorylation. Taken together, these results demonstrate the occurrence in Jurkat cells of a tyrosine kinase pathway specifically coupled to the CD2 molecule. They also suggest a function of the p62-GAP-associated protein as a link between PLC3,-1 and p21ras activation pathways after CD2 activation.
Numerous substrates are tyrosine phosphorylated upon CD2 stimulation of human Jurkat T cells using a mitogenic pair of CD2 monoclonal antibodies, including the phospholipase C (PLC)3'-1-p35/36 complex. Most of these substrates are identically tyrosine phosphorylated after CD3 ligation, suggesting that both stimuli share the same biochemical pathway. We show, however, in this report that a 63-kD protein is specifically phosphorylated on tyrosine residues after ligation of the CD2 molecule. The tyrosine phosphorylation of p63 can be induced independently of other substrates when using a single CD2 mAb recognizing the D66 epitope of the molecule. Importantly, this CD2-induced tyrosine phosphorylation of p63 can also occur in the absence of the CD3~" chain membrane expression, and is also distinct from the protein tyrosine kinases p56 ~ and p59f~. We demonstrate, moreover, that p63 is physically linked with PLC3r-1 and p35/36 upon CD2 stimulation. Finally, we also show that a 62-kD protein coimmunoprecipitating with the p21ras GTPase activating protein (GAP) is heavily tyrosine phosphorylated only after CD2 stimulation. This ultimately suggests that p63 may represent in fact the 62-kD protein that associates with GAP after tyrosine phosphorylation. Taken together, these results demonstrate the occurrence in Jurkat cells of a tyrosine kinase pathway specifically coupled to the CD2 molecule. They also suggest a function of the p62-GAP-associated protein as a link between PLC3,-1 and p21ras activation pathways after CD2 activation.
T he function of CD3 as an integral part of the antigenspecific receptor of T lymphocytes is well established (1) . However, the real function of CD2 is still a debatable question. It is actually considered as a CD3-TCR alternative activation pathway promoting intercellular adhesion as well as T cell activation (2) . Although not specific (CD2 ligands, CD58 and CD59, are ubiquitous molecules) (3), CD2 recognition has been reported to positively regulate CD3-TCR-mediated activation signals (4) suggesting that it may be a costimulatory signal for T cells during the antigen-specific recognition process. This assumption, about a close link between these two T cell activation pathways, was further confirmed by the finding that CD2-mediated T cell activation by specific antibodies required a functional CD3-TCR complex at the T cell surface (5) . Particularly involved in this last phenomenon seems to be the CD3~'chain which is known to be a key element responsible for cell signal transduction through the antigen-specific receptor of T lymphocytes (6) (7) (8) . From all these reasons, it was postulated that CD2 and CD3 shared a common activation pathway. This hypothesis was strengthened by the discovery that both CD3 and CD2 molecules apparently triggered the same cascade of early biochemical events, and especially the phospholipase C (PLC) 1 activation pathway (9, 10) . Indeed, it has been demonstrated that the earliest event after CD3 or CD2 ligation with specific mAbs consisted in the rapid phosphorylation on tyrosine residues of numerous substrates. Among them is a 145-kD substrate, identified as PLC'y-1, one of the main isoforms of PLC in human T lymphocytes whose activity is increased by tyrosine phosphorylation (11, 12) . Activated PLC3'-I would be then responsible for the observed accumulation of the second messengers inositol(1,4,5)-trisphosphate (IP3) and diacylglycerol (DAG). IP3 and DAG are, respectively, involved in intracellular free calcium elevation and protein kinase C activation, two metabolic events critical for the appearance of downstream biological effects after CD3 or CD2 stimulation, i.e., IL-2 production and T cell proliferation (13, 14) . It was concluded, therefore, that CD3 and CD2 were coupled to the same as yet unidentified nonreceptor tyrosine kinase, responsible for PLC3,-1 tyrosine phosphorylation. Several protein tyrosine kinases (PTKs) have been proposed for this coupling. This includes members of the src family of membrane-associated PTK such as p56 ~k, found to be noncovalently associated with the CD4 or CD8 cytoplasmic domain (15) and activated after CD3 or CD2 cell stimulation (16) (17) (18) , as well as the TCR ~" chain-associated kinase p59f~ (19) . The potential role of another ~'-assodated tyrosine phosphorylated protein with PTK activity, ZAP-70, was also envisaged (20) . It has been suggested that both types of kinases (src family PTKs and ZAP-70) may interact to mediate TCR signaling.
Numerous epitopes distinguished by various sets of mAbs are present on the CD2 molecule of human T cells. Some of them are already highly expressed on resting T cells. Others are only weakly detected by the corresponding mAbs partly because of their masking with sialic acid residues on resting T cells (21) . Meanwhile, a full activation via the CD2 molecule in vitro, leading to an activation of the PLC pathway, as well as late functional events, has been demonstrated to require the simultaneous ligation of these two kinds of epitopes (22) . The involvement of CD2 conformational changes induced by the simultaneous binding of mAbs has been put forward, In this report, we demonstrate that stimulation of the CD2 molecule by a mitogenic pair of CD2-specific mAbs, as well as by a single CD2 mAb recognizing the cryptic epitope of the CD2 molecule expressed on Jurkat T cells, is able to specifically induce the tyrosine phosphorylation of a 63-kD protein. Importantly, we present evidence that p63 tyrosine phosphorylation appears even in the absence of CD3~" chain membrane expression. Our results also revealed that tyrosine phosphorylation of p63 can be induced independently of the phosphorylation of PI.C3,-1, suggesting that both proteins are phosphorylated by distinct tyrosine kinases. In addition, they also suggest that a complex containing PI.C3,-1, its associated 35/36-kD protein and p63 can be formed upon CD2 stimulation. Ultimately, using coimmunoprecipitation experiments, we show that p63 may represent in fact the previously described p62 GAP-associated protein.
Materials and Methods
Cells. CD2+CD3 + Jurkat cells, clone E-6.1, were grown in RPMI 1640 medium (Flow Laboratories, Irvine, UK) supplemented with 10% FCS, penicillin (50 U/ml), streptomycin (50 #g/ml), 2 mM r-glutamine, and 1 mM sodium pyruvate, at a density of 0.5 x 106 cells/ml. CD2+CD3 -31. MonodonalAntibodies. mAb UCHT1 (IgG1), specific for CD3~ chain, was obtained from Dr. P. C. L. Beverley (Imperial Cancer Research, London, UK). CD2 mAbs Xll (IgG1), D66 (IgG2b), 0275 (IgG1), G144 (IgM), and GT2 (IgG1) were previously described (21, 22, (24) (25) (26) . mAbs Xll and 0275 recognize the previously described Tl1.1 epitope of the CD2 molecule (2) . mAbs D66 and G144 are specific for a cryptic epitope on resting T cells because of its partial covering with sialic acid residues and which is completely unmasked after T cell activation. For all stimulation experiments, these mAbs were used at 1:500 dilution of an ascitic fluid. The 1C5H5 mAb against the TCR c~ chain of a human T cell clone was produced in our laboratory (27) and used as a control. Anti-PLC3,-1 mAb, antiphosphotyrosine mAb (4G10), and rabbit antiserum against COOH-terminal residues of p56 ~k and rabbit antiserum recognizing p59~ were purchased from UBI Inc.
(Lake Placid, NY were labeled overnight with 5 #Ci/ml myo-[2-3H]inositol (ICN Flow, Orsay, France) in inositol-free medium containing 10% FCS, 2 mM r-glutamine, 1 mM sodium pyruvate, 50 U/ml penicillin, and 50/zg/ml streptomycin. After two washes in KPMI containing 10 mM Hepes, pH 7.2, cells were incubated for 20 min with 10 mM LiC1 at 37~ Aliquots of 106 cells were then stimulated with the indicated mAbs for the indicated period of time at 37~ Reaction was stopped by successive addition of 50 #1 NaOH 0.1 N containing 0.1% Triton X-100, 50 #1 HC1, 0.1 N and 0.2 ml H20. The extraction procedure was continued in borosilicate glass tubes by the addition of 1.5 ml chloroform/methanol (1:2). The organic and aqueous phases were partitioned by the addition of 0.5 ml HzO and 0.5 ml chloroform, and the tubes centrifuged 10 min at 400 g. 1 ml of the aqueous phase was then applied simultaneously with 4 ml of a 5-mM cold myo-inositol on 1 ml Dowex AG 1-X8 anion-exchange resin in the formate form (Bio-Rad Laboratories, Richmond, CA), equilibrated with 0.1 M formic acid. The columns were then washed with 10 ml 0.1 M formic acid and the IP eluted with 5 ml 0.1 M formic acid plus 1.2 M ammonium formate. The eluted radioactivity was quantified by liquid scintillation counting in aqueous scintillant (ACS II; Amersham) and the results expressed in dpm (24) .
Results

Stimulation of Jurkat T Cells through the CD3-TCR Complex or the CD2 Molecule Induces a Different Pattern of Protein
Tyrosine Phosphorylation. CD3-TCR and CD2 activation pathways are thought to be closely linked. First, they have been shown to trigger the same cascade of biochemical events including activation of early PTKs, inositol phosphate production, and increases in intracellular free calcium concentration. Second, it is now generally admitted that the CD2-induced T cell activation needs functional CD3-TCR complex expressed at the cell surface (8, 10). However, as depicted in Fig. 1 , the patterns of proteins tyrosine phosphorylated after CD3 or CD2 ligation with the CD3 mAb UCHT1 ( Fig.   1, top) , or with the CD2 mitogenic pair ofmAbs X11+D66 (Fig. 1, bottom) , were not identical. Indeed, apart from the 145-, 120-, 116-, 100-, 80-, 75-, and 35/36-kD tyrosine phosphorylated proteins induced by both stimuli, we could notice a 66-kD doublet strongly tyrosine phosphorylated over the background level only after CD3 stimulation. Conversely, a 63-kD tyrosine phosphorylated protein was only observed after CD2 ligation. This suggested that different PTKs could be activated depending on whether Jurkat cells were stimulated through CD3-TCR or CD2 molecules. One should notice here that the 145-kD band observed after CD3 or CD2 stimulation corresponded to tyrosine phosphorylated PI.C'y-1 since a single 145-kD protein was revealed by anti-PLC3,-1 mAb in antiphosphotyrosine immunoprecipitates of CD3 or CD2-activated Jurkat cells (data not shown).
Delayed kinetics of tyrosine phosphorylation have been previously evidenced after the activation of PBL with CD2 mAbs as compared with CD3 stimulation (28) . The time course experiments shown in Fig. I demonstrate that the maximum response always occurred later after CD2 stimulation with the mAb pair X11+D66. Usually it was found to peak between 3 and 5 min after the addition of the CD2 pair. In the same assay conditions, tyrosine phosphorylations after CD3 stimulation peaked very early (between 15 and 30 s). It is also clear from Fig. 1 that for a given stimulus, all proteins, including p66 and p63, shared the same tyrosine phosphorylation kinetic. (bottom) for the indicated times. Total cell extracts were resolved on a 8% polyacrylamide gel, transferred to nitrocellulose, and immunoblotted with antiphosphotyrosine mAb 4G10. Positions of molecular size markers are indicated. Exposition times were 10 s for each membrane. Parallelblotting using anti-PLC',/-1 mAb revealed no change in the amount of PLC',/-1 for each stimulation time, indicating that the same quantity of cellular extract was loaded for each sample (not shown).
Tyrosine Phosphorylation of p63 Is Induced upon
mAbs. mAb 0275 recognizes the same epitope as Xll and mAb G144 the same as D66 (25, 26) . mAb GT2 recognizes a third epitope, as evidenced by the lack of competitive binding with the mAbs named above (22) . Cytofluorometry analysis of Jurkat cells after labeling with each of these CD2 mAbs as compared with CD3 mAb UCHT1 is presented in 
fluorescence intensity (XI1, D66, 0275, (7, 144, GT2) or with the CD3 mAb UCHT1. An irrelevant mAb, used as the negative control, is also shown in each panel. All mAbs were used as a 1:400 dilution of an ascitic fluid. Bound mAbs were revealed using goat anti-mouse FITC conjugate and the fluorescence analyzed on a FACScan | cell analyzer.
(Xl1+ D66, Xl1+ G144, GT2 + G144, and 0275 + G144) were able to induce the tyrosine phosphorylation of p63 protein.
None of them could, however, phosphorylate the 66-kD doublet observed after CD3 stimulation. Interestingly, we can see from Fig. 3 A that p63-induced phosphorylation apparently correlated with the presence in the studied combination of mAb D66 or G144 to CD2 receptor. The same results were obtained when using purified CD3 and CD2 mAb instead of ascitic fluid (data not shown). We therefore analyzed the effect of single CD2 mAb on protein tyrosine phosphorylation in Jurkat cells. We were surprised to discover that D66 and G144 could induce p63 tyrosine phosphorylation when used alone (Fig, 3 B) . The fact that neither the single CD2 mAb Xll, nor 0275, nor control ascite fluid, were able to induce the p63 phosphorylation demonstrated its specific induction by stimulating the D66 epitope on the CD2 molecule. It seemed, therefore, that stimulating D66 epitope could activate a PTK acting on p63. Importantly, these results also pointed out that p63 tyrosine phosphorylation occurred independently of PLCT-1 phosphorylation. Indeed, mAb pairs Xl1+ G144 and GT2 + G144 , single CD2 mAb Xli, D66, 0275, or G144 were used for stimulation experiments ofJurkat T cells (5 x 106Aample). After lysis, postnuclear supernatants were loaded on a 8% polyacrylamide gel, and separated proteins were revealed by Western blotting using antiphosphotyrosine mAb 4G10. (C) IP production after CD2 stimulation. Jurkat cells (106/ml) were labeled with myo-[2-3H]inositol and divided in aliquots (106 cells/sample) which were then stimulated with UCHT1 for 1 min, or CD2 mAbs pairs X11+D66, X11+G144, X11+GT2, GT2+G144, or O275+G144 for 5 min, or single CD2 mAb Xll, D66, O275, or G144 for 5 min, or were left unstimulated (-). IPs were measured as described in Materials and Methods. Results are expressed in dpm as the mean of three separate experiments.
could tyrosine phosphorylate p63 without inducing any detectable tyrosine phosphorylation of the 145-kD band corresponding to PLCT-1 (Fig. 3 A) . In the same way, D66 or G144 mAbs used alone triggered p63 but not PLC3,-1 tyrosine phosphorylation (Fig. 3 B) . This latter result was confirmed by the fact that neither Xl1+ G144 and GT2 + G144 pairs, nor mAbs D66 or G144 used alone, could trigger inositol phosphate production (Fig. 3 C) , as compared with the pairs that were able to trigger the phosphorylation of PLC3,-1 (see Fig. 3 A) . Accordingly, in parallel experiments, we found Figure 4 . Tyrosine phosphorylation of p63 occurs independently of membrane CD3-TCR expression. 31.13 cells (phenotype CD2 +CD3-) were stimulated with the CD3 mAb UCHT1 for 1 min, or the mAb pair X11+D66 for 5 min, or were left unstimulated (-). After lysis, total cellular extracts were run on a 8% SDS-PAGE. Proteins were then revealed by immunoblotting using antiphosphotyrosine mAb 4G10. As a negative control, the same experiments were performed in a variant cell line derived from 31.13 by limiting dilution, and lacking cell surface CD2. a sustained intracellular free calcium increase only with those combinations leading to tyrosine phosphorylation of PLCy-1 (data not shown).
p63 Tyrosine Phosphorylation Occurred Independentl2/ of the CD3-TCR Complex, Complete activation process of Jurkat T cells through the CD2 pathway, including early protein tyrosine phosphorylation, followed by inositol phosphate production, increased in intracellular free calcium concentration and lately IL-2 synthesis, is known to require functional CD3-TCR complex at the cell surface. Particularly required for that process seems to be the CD3~'chain which is thought to be responsible, at least in part, for signal transduction mediated after the stimulation of the CD3-TCR molecular complex (6, 7). Whether or not tyrosine phosphorylation of p63 was dependent on CD3-TCR expression seemed, therefore, an important question to answer. For that purpose, we used a previously described Jurkat cell variant, termed 31.13, lacking the TCR/3 chain gene and that fails to express any membrane CD3-TCR complex or CD3~'chain (8, 23) . As shown in Fig. 4 (left) , stimulation of this cell variant with the CD2 mAb pair Xl1+ D66 also induced the tyrosine phosphorylation of p63, although this induction was usually weaker as in the parental cell line. Importantly, it was not accompanied by the tyrosine phosphorylation of the other substrates observed in the wild type of Jurkat cells (see Fig. 1, bottom) .
In the same cell line, the CD3 mAb UCHT1 did not stimulate any phosphorylation, a finding which was consistent with the absence of cell-surface CD3. As a control, we have also used in this experiment a cell clone, selected from the 31.13 variant, and lacking CD2 surface expression (data not shown). No tyrosine phosphorylation of p63 could be observed in this clone after stimulation with the CD2 mAb pair Xl1+ D66 (Fig. 4, right) . Altogether these findings demonstrated that p63 tyrosine phosphorylation only depended on the CD2 pathway and did not require CD3-TCR or ~" chain expression. These results underlined again the independence of the p63 tyrosine phosphorylation pathway since no PLC'y-1 phosphorylation could be observed after CD2 stimulation of the 31.13 variant. were unstimulated (-), or activated with the CD3 mAb UCHT1 for 1 min, the CD2 mAb pair X11+D66 or the mAb D66 alone for 5 min. Cells were then lysed in a lysis buffer containing 1% digitonin and precleared lysates were immunoprecipirated with anti-PI.C3,-1 mAb. Immune complexes were resolved by SDS-PAGE on a 8% acrylamide gel, and Western blot analysis using antiphosphotyrosine mAb 4G10 was performed. Positions of coimmunoprecipitating P1-C3,-1, p35/36, and p63 are indicated. No bands except mAb H chains could be detected in immunoprecipitates performed with an irrelevant mAb (not shown). (b) In a separate experiment, Jurkat cells were left unstimulated (lane 1) or were activated using the CD2 mAb pair Xl1+ D66 (lanes 2, 3, and 4), and treated as above. Lysates were then immunoprecipitated with anti-PLC~-I mAb (lanes I and 2) or rabbit antiserum recognizing the COOH-terminal residues of p56~ (lane 3) or rabbit antiserum specific for p59f~ (lane 4). Immunoprecipitates were resolved by SDS-PAGE and revealed using antiphosphotyrosine mAb 4G10. Positions of tyrosine phosphorylated bands of p56~, p59f~, and p63 are indicated. I and 4) , or were activated with the CD3 mAb UCHT1 for 1 min (lanes 2 and 5) , or the CD2 mAb pair X11+D66 for 5 min (lanes 3 and 6). Cells were lysed in a lysis buffer containing 1% digitonin and the lysates immunoprecipitated with anti-PI.C~-I mAb (lanes I-3) or anti-GAP mAb (lanes 4--6).
Immunoprecipitates were then resolved on a 8% acrylamide gel and transferred onto nitrocellulose. The membrane was then divided into two parts. 
p63 Coimmunoprecipitates with PLGT-1 and Is Distinct from a Tyrosine Phosphorylated Form of p56 r or p56f~ Kinases.
We have shown that p63 was specifically tyrosine phosphorylated after appropriate CD2 stimulation. That it may represent a link in the corresponding biochemical cascade was therefore possible. Thus, a possible important role for p63 to play in the CD2 transduction pathway would be to associate with PLC~,-1 after receptor stimulation. We have therefore examined tyrosine phosphorylated proteins that coimmunoprecipitated with PLC2r after CD2 stimulation of Jurkat T cells. For that purpose, cells were incubated with Xll+D66 for 5 rain before lysis and immunoprecipitation with anti-PLC3'-I mAb, and then probed with antiphosphotyrosine mAb. As shown in Fig. 5 a, the 63-kD tyrosine phosphorylated protein was found to coprecipitate with PI.C'y-1 after CD2 ligation using the mitogenic pair Xll+D66. As previously reported (4), p35/36 also coimmunoprecipitated with PLCqr-1 upon these conditions of CD2 stimulation. The other proreins present in the anti-PLCy-1 immunoprecipitate were identical in unstimulated or in CD2-stimulated Jurkat cells. These results thus suggested that p63 formed a complex with PLC3,-1 and p35/36 after CD2 stimulation, even though these proteins were likely phosphorylated by distinct PTKs. Interestingly, we found that after Jurkat cell stimulation with D66 mAb alone, p63 also could be immunoprecipitated with PLC3,-1 (Fig. 5 a) although, as we described above (see Fig.  3 B) , PLC'y-1 was not tyrosine phosphorylated in that experimental condition. In parallel experiments, PLC3r immunoprecipitations were also performed after CD3 stimulation. As shown in Fig. 5 a the CD3-specific 66-109 tyrosine phosphorylated doublet was not detected in the anti-PLC3r immunoprecipitate contrary to the PLC'y-l-associated tyrosine phosphorylated protein p35/36. Since p63 tyrosine phosphorylation occurred specifically after CD2 triggering, one could expect some physical association with its corresponding surface receptor. However, we were repeatedly unable to coprecipitate p63 with the CD2 mAb Xll (data not shown). This probably indicates that p63 and CD2 did not associate or that their association was very weak, very unstable, or transient, since we have used digitonin as a detergent that allows mild lysis conditions and preserves protein interactions.
The appearance of slow migrating species of p56 ~ after CD2 stimulation of Jurkat cells has been reported (16) . Moreover, it has been demonstrated recently that the CD2 triggering could induce an increase in p56 ~ activity in the 31.13 Jurkat cell variant (18) . This suggested that p63 might be p56 k~ itself. Therefore, p56 ~ immunoprecipitation from the lysate of Jurkat cells stimulated with mAbs Xll+D66 was performed and revealed using antiphosphotyrosine antibodies. As shown in Fig. 5 b, no tyrosine phosphorylated species of p56 ~ were found to comigrate with p63 (compare lanes 2 and 3). One has to notice that a few amounts of phosphotyrosine-labeled material appeared in the 56-kD region in the PLC~r immunoprecipitate of CD2-stimulated cells as compared with the control (compare lanes 1 and 2 of Fig. 5 b) . This could correspond to small amounts of tyrosine phosphorylated p56 ~ coimmunoprecipitating with PLC3,-1, as recently shown in TCR-stimulated Jurkat cells (29) . Similar conclusions arose from immunoprecipitation experiments using anti-p59fr" antibodies since, once again, no tyrosine phosphorylated form of p59fr~ migrated as a 63-kD band after the stimulation of Jurkat cells with the couple of CD2 mAbs Xll+D66 (Fig. 5 b) .
The 62-kD Protein Coimmunoprecipitating with GAP Is Specifically Tyrosine Phosphorylated after CD2 Stimulation of Jurkat Cells.
A 62-kD protein has been described to be highly tyrosine phosphorylated and to associate with GAP after signaling by tyrosine kinase growth factor receptor or in v-src tyrosine kinase-transformed cells (30) . We therefore investigated whether p63 could correspond to this protein. Cell extracts from CD3 or CD2-stimulatedJurkat cells were immunoprecipitated in paralld with anti-PLC'y-1 or anti-GAP mAb, and the immune complexes probed in Western blot with GAPspecific mAb or antiphosphotyrosine mAb. As shown in Fig.  6 A, GAP mAb recognized in Jurkat cells a band with a molecular mass of 120 kD corresponding to one of the previously described forms of mammalian p21ras GAP (31) . This band was only present in GAP immunoprecipitates. Importantly, we found in this experiment, as shown in Fig. 6 B, that a strong tyrosine phosphorylated 62-kD protein could be observed in anti-GAP immunoprecipitates from CD2-stimulated Jurkat cells (lane 6). This band was only weakly labeled in control or CD3-stimulated cells (Fig. 6 B, lanes  4 and 5) . Clearly, this protein comigrated with the band that we found recognized by antiphosphotyrosine mAb in the PLC3,-1 immunoprecipitate of CD2-stimulated Jurkat cells (Fig. 6 B, lane 3) . Taken together with the previous data showing that p63 was strongly tyrosine phosphorylated only after CD2 stimulation, these results thus suggested that p63 might represent in fact the 62-kD GAP-associated protein.
Besides p62, another tyrosine phosphorylated protein of 190 kD has been previously demonstrated to also associate with GAP (30, 32) . Therefore, we investigated if p190 also could be differentially phosphorylated after CD2 and CD3 stimulation of Jurkat cells. As shown in Fig. 7 A whereas p62 was found heavily and specifically labded in anti-GAP immunoprecipitates from CD2-stimulated cells, confirming the results of Fig. 6 , only a very tenuous tyrosine phosphorylation of p190 was observed that needed overexposure of the membrane to be evidenced (Fig. 7 B) . Moreover, it was found tyrosine phosphorylated even in unstimulated cells. One has to notice here that only a weak tyrosine phosphorylation of GAP could be observed in paralld, as also shown in Fig. 7 B. Interestingly, GAP appeared to be similarly phosphorylated in CD3-and CD2-stimulated cells. However, in contrast with p190, it was not tyrosine phosphorylated in unstimulated cells. These results ultimately suggest that in the so-called GAP complex, only the p62 protein is highly tyrosine phosphorylated upon CD2 stimulation of Jurkat T cells.
Discussion
The necessity of the CD2 molecule as an alternative activation pathway near the antigen-specific CD3-TCR complex, and its putative role, remain unknown. It has been shown that T cell activation through CD2 requires a functional CD3-TCK complex at the cell surface (5, 8, 23, 33) , suggesting that signals triggered through these receptors were 1593 Hubert et al.
transduced by the same way. According to this idea, it has been reported that stimulating T cells with mAbs specific for CD3 or CD2 induces tyrosine phosphorylation of the same set of polypeptides (34) . However, in contradiction to this, Jin et al. (35) demonstrated in Jurkat cells that CD3-TCK and CD2 pathways should be distinct since a 68-kD tyrosine phosphorylated protein was induced after CD3 but not CD2 stimulation. In the same way, recent studies in rat thymocytes revealed that different tyrosine phosphorylated proteins could be coimmunoprecipitated with CD3 or CD2 molecules (36) . Here we provide evidence that different pathways could be activated depending on whether or not Jurkat T cells were stimulated through the CD3 or different epitopes of the CD2 molecule.
Numerous substrates are tyrosine phosphorylated after CD3 or CD2 stimulation ofJurkat T cells using a mitogenic pair of CD2 mAbs (28, 37) . The identity of most of these tyrosine phosphorylated proteins is not yet known, except for some of them, such as PLCqr-1, the CD3~" chain (38) , the p95 ray protooncogene (39) , or the kinases p56 ~k (16, 18) , pS~ (19) , and ZAP-70 (20) . The tyrosine phosphorylation of many of these proteins, including PLC~/-1 and a 35/36-kD phosphoprotein previously shown to be associated in a stable complex (4), appeared to be common to both stimuli and was found to correlate with the rapid production of inositol phosphates leading in both cases to intracellular flee calcium increases. This suggested that these substrates might be phosphorylated by the same tyrosine kinase, an assumption further strengthened by the finding that, as also shown in this report (Fig. 1) , these proteins shared for a given stimulus an identical tyrosine phosphorylation kinetic. This PTK should be activated after CD3 or CD2 stimulation, and should therefore belong to a common signal transduction pathway.
Our results showed that besides this common pattern of tyrosine phosphorylated proteins, an additional 63-kD band could be induced specifically after CD2 triggering of Jurkat cells using different pairs of CD2 mAbs. Importantly, the tyrosine phosphorylation of p63 could be dissociated for the tyrosine phosphorylation of the PLC~/-1-p35/36 complex as evidenced when using a mAb directed against the D66 epitope of the CD2 molecule. Accordingly, no IP production or calcium response (data not shown) was induced in that case. This result suggested that tyrosine phosphorylation of p63 on the one hand, and of the PLC3,-1-p35/36 complex on the other, occurred through distinct PTKs activated after CD2 stimulation ofJurkat T cells. Interestingly, our results may lead to a similar conclusion for the CD3 pathway with regard to our finding of a 66-kD tyrosine phosphorylated doublet only after CD3 stimulation. Indeed, tyrosine phosphorylation of this doublet was not induced when using a comitogenic pair of CD2 mAbs, whereas as previously mentioned, the whole pattern was similar to the one obtained after CD3 activation. This 66-kD doublet could represent the CD5 surface antigen since CD5 appears as a 67-69-kD doublet which is tyrosine phosphorylated by CD3 in Jurkat T cells (40) (41) (42) . Of course, it can be also hypothesized that the same kinase would be associated with CD3 and CD2 and would phosphorylate either p66 or p63 as a consequence of the exclusive association of p66 with CD3 and p63 with CD2. However, our experiments with the CD2+CD3 -31.13 Jurkat cell variant supported the idea of a distinct kinase activated after CD2 triggering.
As mentioned above, T cell activation through CD2 has been previously shown to require functional CD3-TCR complex at the cell surface, and especially functional CD3~" chain (8) , thus supporting the classical assumption of a common CD3-CD2 signaling pathway. Accordingly, tyrosine phosphorylation of the PLC~/-1-p35/36 complex could not have been induced in the ~'-negative 31.13 variant either with CD3 mAb or a mitogenic pair of CD2 mAbs. However, the isolate tyrosine phosphorylation of p63 was still observable after cell stimulation through the CD2 molecule, demonstrating that this CD2-dependent tyrosine kinase pathway was distinct from the tyrosine kinase pathway(s) linked to the CD3 molecular complex. We do not know which kinase is actually involved in the phosphorylation of p63. p56 k~ might be one candidate. Indeed, this kinase has been demonstrated to still be activated via CD2 in the 31.13 variant (18) . However, if this is true, then p63 also should be present after CD3 stimulation in the Jurkat wild-type line since this stimulus has been reported, although this is a very controversial problem, to activate p56 ~k (18) . Concerning the two other PTKs which are clearly involved in the human T cell activation process, p59fr" and ZAP-70, both have been demonstrated to be associated with the CD3 molecular complex and especially with its ~" chain (19, 43) . Thus, according to the results obtained in the 31.13 variant, their contribution to p63 phosphorylation is unlikely.
Questions remained about p63 identity. We initially thought that it might be p56 ~ itsels Indeed, slow migrating species of the enzyme have been evidenced after CD2 stimulation in Jurkat cells. Moreover, as noted above, the CD2 triggering still induced an increase in p56 ~k kinase activity in the Jurkat cell variant 31.13 (18) . However, using immunopredpitation experiments, we found that in CD2-stimulated cells, the highest slow migrating tyrosine phosphorylated species of p56 ~ did not comigrate with p63, suggesting that this one might be a distinct protein. In the same way, the p59f~ kinase did not comigrate with p63, eliminating the possibility that they could be identical. This question about an identity between p56 ~k and p63 was reconsidered by our finding that, at least, PLC3~-I, p35/36, and p63 were found to be associated after CD2 stimulation with a mitogenic combination of mAbs. It has been shown recently using a PLC~/-1-containing fusion protein, that a small amount (<5%) of tyrosine phosphorylated p56 k~ could associate with PLC7-1 after Jurkat cell stimulation with a TCIL-specific mAb (29) . Accordingly, it appeared from our experiments that small amounts of p56 ~ labeled by antiphosphotyrosine antibodies could be immunoprecipitated with PLC3,-1 after CD2 stimulation of Jurkat cells (Fig. 5 b, lane 2 ; the p56 ~ comigrating doublet over the Ig band), a result further confirmed by in vitro kinase assays (data not shown). But no p63-comigrating forms could be again observed in this latter experiment. Interestingly, we found that immunoprecipitation of p63 by anti-PLC~-i also could be achieved in D66-stimulated Jurkat cells, in a stimulation system where no detectable tyrosine phosphorylated PLC',/-1 has been observed. This indicates that p63 associates at least in part with nonphosphorylated PLC'y-1, and could therefore represent a protein that regulates PI.C3,-1 during the CD2 T cell activation process.
We have further hypothesized that p63 could represent the p62 GAP-associated protein. Our results demonstrate the presence of a highly tyrosine phosphorylated 62-kD protein coimmunoprecipitating with GAP in ]urkat T cell extracts after CD2 stimulation. At the same time, GAP was much less tyrosine phosphorylated. These findings were in complete agreement with the results recently obtained by Gold et al. (44) in B lymphoma cell lines after mIg cross-linking, p62 was first discovered in oncogene tyrosine kinase-transformed fibroblasts such as v-src or v-fps (30) . In these cells, p62 was found to be constitutively and highly tyrosine phosphorylated without cell stimulation and to coimmunoprecipitate with GAP. Tyrosine phosphorylation of p62 and coimmunoprecipitation with GAP was also dearly evidenced in rat fibroblasts transfected with the human EGF receptor, but only after EGF stimulation (30) . The same results were obtained in EBV immortalized B cells stimulated with an anti-IgM mAb (44) . Taken together, these results suggest that p62 was a preferential substrate of transforming or mitogenic tyrosine kinases. This would probably explain why the tyrosine phosphorylation of p62 appeared to be so strong in Jurkat cells as compared with peripheral blood T cells. Indeed, in these cells, proteins migrating in the 66-and 63-kD regions were always very weakly labeled, and the imbalance between the CD3 and the CD2 activation pathway in stimulating the tyrosine phosphorylation of p63 was very difficult to evidence (data not shown). It is thus possible that this event represents in physiological T cells a phenomenon that is difficult to detect and that is greatly enhanced in Jurkat cells, presumably as a consequence of the malignant transformation and/or deregulated activities of the responsible kinases. This assumption would be in agreement with the fact that p62 was found to be highly phosphorylated only in transformed cells (45) . Interestingly, we observed that tyrosine phosphorylated p62 could not be recovered from GAP immunoprecipitates performed on CD3-stimulated Jurkat cells. In addition to the fact that this is an additional argument for an identity of p62 with the PLC3~-1-associated 63-kD protein, this ultimately suggests that different regulations of the ras/GAP pathway between CD2 and CD3 may take place in Jurkat cells. Indeed, p62 binding to GAP protein is thought to inhibit its GTPase activity, thus favoring the maintenance of the activated form of p21ras (46) . How p62 would associate with PLC-y-1 is an as yet unresolved question. However, tyrosine phosphorylated p62 has been demonstrated to associate with GAP through its SH2 domain (46) . A similar mechanism therefore might be involved in its association with PLC3'-I, which also contains such domains.
A full activation process through the CD2 molecule in vitro needs the simultaneous use of two antibodies directed against distinct epitopes of the molecule. Thus far, it has been speculated that this peculiarity would reflect the existence CD2 Stimulation of Human T Cells of two different physiological ligands for CD2. This is now confirmed by the findings that two different molecules, CD58 (LFA3) and CD59, could bind specifically to CD2. Indeed, whereas CD58 binds with a high affinity to the CD2 epitope recognized by a mAb such as Xll, which defines an external epitope of the molecule, it is now suggested that the CD59 molecule would bind to another epitope on the CD2 receptor (3) and would have potentiating effects with CD58 on T ceU activation (47) . One intriguing problem, however, when discussing the possible function of CD2, is that it represents one of the earliest call-surface markers to appear during ontogeny. Thus, early prothymocytes which further differentiate to mature T cells express CD2. However, they do not express CD3-TCR on their membrane. In these cells, although CD2 does not trigger intracellular calcium elevation or IL-2 synthesis, it induces nevertheless protein tyrosine phosphorylation, suggesting that CD2 would in addition to its coreceptor function, play its own role in T cell activation (48) . Our results open new prospects concerning a putative CD2-dependent biochemical cascade involved in T cell differentiation. Alternatively, this may represent a specific CD2-1inked regulation pathway of T cell activation, since p62 is believed to contribute to p21ras activation and since it was shown to associate with PLC~/-1 upon CD2 stimulation.
